Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in GALT — Galectin Therapeutics Inc

CIK 1423053 MIAMI, FL
Back to GALT Full portfolio

Position in GALT

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$921,972
+$111,868 QoQ
Shares Held
198,701
-31.6% QoQ
Ownership
0.197%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 98 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GALT Over Time

Shares Held

Position Value (USD)

Derivatives in GALT

reported options exposure · as of Jun 30, 2026
CallValue
$597,168
CallShares
128,700
PutValue
$981,824
PutShares
211,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,758,606 across 435 Biotechnology names. GALT ranks #233 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in GALT

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $597,168 128,700
2026-06-30 $981,824 211,600
2026-06-30 $921,972 198,701
2026-03-31 $112,158 40,200
2026-03-31 $810,104 290,360
2026-03-31 $91,512 32,800
2025-12-31 $114,400 27,500
2025-09-30 $302,337 71,306
2025-09-30 $306,552 72,300
2025-09-30 $52,576 12,400
2025-06-30 $145,801 69,100
2025-06-30 $115,628 54,800
2025-06-30 $217,956 103,297
2025-03-31 $133,590 109,500
2025-03-31 $144,692 118,600
2024-12-31 $101,136 78,400
2024-12-31 $746,523 578,700
2024-09-30 $171,875 62,500
2024-09-30 $141,900 51,600
2024-06-30 $6,102 2,700
2024-06-30 $1,859 823
2024-06-30 $30,736 13,600
2024-03-31 $58,605 24,521
2024-03-31 $18,403 7,700
2023-12-31 $11,636 7,010
2023-12-31 $7,304 4,400
2023-12-31 $5,478 3,300
2023-06-30 $616 428
2023-06-30 $13,968 9,700
2023-06-30 $3,456 2,400
2023-03-31 $2,683 1,278
2023-03-31 $36,960 17,600
2023-03-31 $6,930 3,300
2022-12-31 $339 300
2022-12-31 $94,505 83,634
2022-12-31 $5,085 4,500
2022-09-30 $29,567 18,140
2022-06-30 $14,017 10,700
2022-03-31 $36,708 22,800
2021-12-31 $89,800 43,382
2021-12-31 $161,253 77,900
2021-09-30 $94,795 24,432
2021-09-30 $327,860 84,500
2021-09-30 $71,392 18,400
2021-06-30 $181,440 56,700
2021-06-30 $67,520 21,100
2021-03-31 $53,165 24,500
2020-12-31 $22,400 10,000
2020-12-31 $43,305 19,333
2020-12-31 $116,256 51,900